Krajina: Austrália
Jazyk: angličtina
Zdroj: Department of Health (Therapeutic Goods Administration)
Neomycin; Gramicidin; Triamcinolone acetonide; Nystatin
KENACOMB OINTMENT- Consumer Medicine Information Page 1 of 4 KENACOMB ® TOPICAL OINTMENT _Triamcinolone acetonide, nystatin, gramicidin, neomycin _ CONSUMER MEDICINE INFORMATION (CMI) WHAT IS IN THIS LEAFLET This leaflet answers some common questions about KENACOMB ointment. READ IT CAREFULLY BEFORE APPLYING YOUR MEDICINE. It does not contain all the available information. Some of the information contained in this leaflet may not apply to you. It does not take the place of talking to your doctor or pharmacist. All medicines have risks and benefits. Your doctor has weighed the risks of you using KENACOMB ointment against the benefits they expect it will have for you. ASK YOUR DOCTOR OR PHARMACIST IF YOU HAVE ANY CONCERNS ABOUT USING THIS MEDICINE. KEEP THIS LEAFLET WITH THE MEDICINE. You may need to read it again. _ _ _ _ _ _ WHAT KENACOMB OINTMENT IS USED FOR KENACOMB is an ointment containing a combination of the following medicines: • _nystatin _which is used to treat skin infections caused by a family of yeast-like fungi called _Candida_. This condition is known as candidiasis or thrush. _Candida _ _albicans _is the most common cause of thrush. Symptoms of skin infections caused by _Candida _include itching, redness, small blisters cracking or scaling. These infections usually occur between folds of the skin or around the nails. • _neomycin_, is an antibacterial medicine • _gramicidin_, is an antibacterial medicine • _triamcinolone acetonide_, an anti- inflammatory medicine which stops redness and itching. KENACOMB ointment is used to relieve the redness and itching of skin conditions which are likely to become infected or are already infected. Your doctor may have prescribed this ointmen Prečítajte si celý dokument
KENACOMB OINTMENT- Product Information Page 1 of 6 PRODUCT INFORMATION KENACOMB DESCRIPTION KENACOMB contains the synthetic corticosteroid triamcinolone acetonide; the antifungal agent nystatin; and the antibiotic agents neomycin sulphate and gramicidin. Kenacomb for topical use contains triamcinolone acetonide 1mg (0.1%). neomycin 2.5mg (as sulphate), gramicidin 0.25mg and nystatin 100,000 units per gram in an ointment base. PHARMACOLOGY Triamcinolone acetonide, a topical corticosteroid has anti-inflammatory, antipruritic and vasoconstrictive actions. The mechanism of anti-inflammatory activity of topical corticosteroids is unclear. Various laboratory methods, including vasoconstrictor assays, are used to compare and predict potencies and/or clinical efficacies of the topical corticosteroids. There is some evidence to suggest that a recognisable correlation exists between vasoconstrictor potency and therapeutic efficacy in man. Neomycin and gramicidin provide antibacterial activity against microorganisms likely to be responsible for topical bacterial infections. These ingredients give symptomatic relief of the pain, burning and itching of infected skin, while combating the relevant bacterial and/or monilial infection. PHARMACOKINETICS The extent of percutaneous absorption of topical steroids is determined by many factors including the vehicle, the integrity of the epidermal barrier and the use of occlusive dressings. Topical corticosteroids can be absorbed from normal intact skin. Inflammation and/or other disease processes in the skin increase Prečítajte si celý dokument